Skip to main content
Equibles

Metis Global Partners, LLC

Position in RPRX — Royalty Pharma plc

CIK 1594916 San Diego, CA
Back to RPRX Full portfolio

Position in RPRX

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$3,329,100
+$424,997 QoQ
Shares Held
59,374
-1.9% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#230
of 646 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Metis Global Partners, LLC holds $12,809,533 across 8 Biotechnology names. RPRX ranks #2 (26.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 10,929 $5,428,762
2 RPRX
Royalty Pharma plc
This page 		59,374 $3,329,100
3 REGN
Regeneron Pharmaceuticals, Inc.
 2,439 $1,520,814
4 ALNY
Alnylam Pharmaceuticals, Inc.
 4,009 $1,206,829
5 INCY
Incyte Corp
 4,068 $461,148
6 MRNA
Moderna, Inc.
 6,452 $451,833
7 TECH
BIO-TECHNE Corp
 2,918 $206,156
8 PBYI
Puma Biotechnology, Inc.
 25,264 $204,891

All Filings in RPRX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,329,100 59,374
2026-03-31 $2,904,103 60,540
2025-12-31 $2,484,165 64,290
2025-09-30 $2,301,526 65,236
2025-06-30 $2,445,716 67,880
2025-03-31 $1,149,350 36,921
2024-12-31 $914,814 35,861
2024-09-30 $614,939 21,737
2024-06-30 $517,142 19,611
2024-03-31 $411,392 13,546
2023-12-31 $375,479 13,367